Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.465 USD | +1.74% | +1.05% | -1.36% |
13/03 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
13/03 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.36% | 77.61M | |
-3.09% | 102B | |
+1.05% | 96.29B | |
+1.78% | 22.18B | |
-15.78% | 21.2B | |
-9.58% | 18.31B | |
-38.74% | 17.38B | |
-13.48% | 16.36B | |
+6.57% | 13.97B | |
+33.68% | 12.17B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- Earnings Flash (SPRO) SPERO THERAPEUTICS Posts Q3 Revenue $2M